NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 55 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $41,000 | +105.0% | 299,000 | +54.1% | 0.00% | +33.3% |
| Q4 2018 | $20,000 | -55.6% | 194,000 | 0.0% | 0.00% | -40.0% |
| Q3 2018 | $45,000 | +2.3% | 194,000 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $44,000 | -37.1% | 194,000 | 0.0% | 0.01% | -44.4% |
| Q1 2018 | $70,000 | +14.8% | 194,000 | +14.8% | 0.01% | +28.6% |
| Q4 2017 | $61,000 | +771.4% | 169,000 | +956.2% | 0.01% | +600.0% |
| Q3 2017 | $7,000 | – | 16,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |